Učitavanje...
Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis
BACKGROUND: Hypertension is a prevalent condition among SARS-CoV-2 infected patients. Whether renin–angiotensin–aldosterone system (RAAS) inhibitors are beneficial or harmful is controversial. METHODS: We have performed a national retrospective, nonexperimental comparative study from two tertiary ho...
Spremljeno u:
| Izdano u: | Med Clin (Barc) |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier España, S.L.U.
2022
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8101788/ https://ncbi.nlm.nih.gov/pubmed/34088524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.medcli.2021.04.005 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|